Detalles de la búsqueda
1.
A genetic variation in fucosyltransferase 8 accelerates HIV-1 disease progression indicating a role for N-glycan fucosylation.
AIDS
; 37(13): 1959-1969, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37598360
2.
Activity of broadly neutralizing antibodies, including PG9, PG16, and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemic.
J Virol
; 85(14): 7236-45, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21561918
3.
Genetic variations in the host dependency factors ALCAM and TPST2 impact HIV-1 disease progression.
AIDS
; 34(9): 1303-1312, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32287057
4.
The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype.
AIDS Res Hum Retroviruses
; 32(10-11): 1135-1142, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26910384
5.
Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level.
Nat Med
; 16(9): 995-7, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20802498
6.
Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodies.
J Virol
; 81(16): 8533-42, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17522228
7.
Escape of human immunodeficiency virus type 1 from broadly neutralizing antibodies is not associated with a reduction of viral replicative capacity in vitro.
Virology
; 363(2): 447-53, 2007 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-17355886
8.
T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates.
Virology
; 359(1): 92-104, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17052738
Resultados
1 -
8
de 8
1
Próxima >
>>